Pulmonx (LUNG) FCF Margin (2019 - 2025)

Pulmonx's (LUNG) quarterly FCF Margin came in at 36.52% in Q3 2025, down 548.0% year-on-year from 8.15% in Q3 2024, and down 120.16% on a QoQ basis from 16.59% in Q2 2025.

Pulmonx (LUNG) FCF Margin (2019 - 2025) Analysis & Trends

Pulmonx (LUNG) has 7 years of FCF Margin data on file, last reported at 36.52% in Q3 2025.

  • On a quarterly basis, FCF Margin fell 548.0% year-over-year to 36.52% in Q3 2025; TTM through Sep 2025 was 35.15%, a 691.0% increase from a year earlier, with the FY2024 full-year figure at 37.9%, up 1703.0% from the prior year.
  • FCF Margin for Q3 2025 stood at 36.52%, down from 16.59% in the prior quarter.
  • Over the last five years, FCF Margin for LUNG reached as high as 16.59% in Q2 2025 and fell as low as 144.31% in Q1 2022.
  • Historically, FCF Margin has averaged 64.6% across 5 years, with a median of 58.92% in 2022.
  • Across the five-year window, FCF Margin surged 10738 bps in 2021 and sank 3782 bps in 2022, its largest moves.
  • Year by year, FCF Margin stood at 104.52% in 2021, then soared by 44 bps to 58.92% in 2022, then rose by 25 bps to 44.1% in 2023, then jumped by 34 bps to 29.06% in 2024, then slipped by 26 bps to 36.52% in 2025.
  • Per Business Quant data, the three most recent FCF Margin figures were 36.52% in Q3 2025, 16.59% in Q2 2025, and 59.9% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 8.20%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 6.89%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 21.26%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 3.29%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -1.28%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 37.67%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 6.68%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.18%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Pulmonx 49.94 Mn -19.81 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -36.52%
Jun 30, 2025 -16.59%
Mar 31, 2025 -59.90%
Dec 31, 2024 -29.06%
Sep 30, 2024 -31.04%
Jun 30, 2024 -31.85%
Mar 31, 2024 -63.12%
Dec 31, 2023 -44.10%
Sep 30, 2023 -49.44%
Jun 30, 2023 -43.12%
Mar 31, 2023 -89.91%
Dec 31, 2022 -58.92%
Sep 30, 2022 -81.14%
Jun 30, 2022 -70.96%
Mar 31, 2022 -144.31%
Dec 31, 2021 -104.52%
Sep 30, 2021 -56.02%
Jun 30, 2021 -110.29%
Mar 31, 2021 -106.49%
Dec 31, 2020 -80.30%